| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9257575 | Critical Reviews in Oncology/Hematology | 2005 | 11 Pages |
Abstract
The step towards a biology adapted treatment of AML is long and requires the combined efforts of researchers, clinicians and the pharmaceutical industry. The first steps towards this goal have been taken and give rise to the hope for more effective and more specific therapies of AML.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
W. Hiddemann, K. Spiekermann, C. Buske, M. Feuring-Buske, J. Braess, T. Haferlach, C. Schoch, W. Kern, S. Schnittger, W. Berdel, B. Wörmann, A. Heinecke, C. Sauerland, Th. Büchner,